ShangPharma Corp. (SHP) Misses Q4 EPS by 4c
ShangPharma Corp. (NYSE: SHP) reported Q4 EPS of $1.33, $0.04 worse than the analyst estimate of $1.37. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.13 billion.
For earnings history and earnings-related data on ShangPharma Corp. (SHP) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
For earnings history and earnings-related data on ShangPharma Corp. (SHP) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- UPDATE: Auriga Starts Teva Pharma (TEVA) at Hold; Sidelined Until New CEO Is Convincing
- UPDATE: Youku.com (YOKU) Misses Q1 EPS by 1c; Sees Q2 Sales Up 90-100% YoY
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
